Codeine Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : January 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC018021
Codeine Market by Type (Codeine Tablet, Codeine Capsules, Codeine Injection, Codeine Syrups) Application (Relieve Cough, Anesthesia and Sedation, Treat Mild to Moderate Pain) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The codeine market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Codeine is a part of a group of medications known as opioids. Codeine, an opioid analgesic, was initially endorsed in the US in 1950 and is a medication used to diminish pain by expanding the limit for pain without disabling awareness or modifying other tactile capacities. Opiates, such as, codeine are derived from the poppy plant, Papaver somniferum (Papaveraceae). Codeine is used as a focal pain relieving, calming, hypnotic, antinociceptive, and antiperistaltic specialist, and is likewise prescribed in specific illnesses with perpetual coughing.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global codeine market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Noramco
- Aesica
- Tasmanian Alkaloids
- Northeast pharmaceutical Group
- Luxembourg Medicine
- Qinghai Pharmaceutical Factory
- Marching Pharmaceutical
- Bright Future Pharmaceuticals Factory
- Europharm Laboratoires
- Macfarlan Smith
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Codeine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Codeine Tablet
o Codeine Capsules
o Codeine Injection
o Codeine Syrups
· Codeine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Relieve Cough
o Anesthesia and Sedation
o Treat Mild to Moderate Pain
· Codeine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Noramco
o Aesica
o Tasmanian Alkaloids
o Northeast pharmaceutical Group
o Luxembourg Medicine
o Qinghai Pharmaceutical Factory
o Marching Pharmaceutical
o Bright Future Pharmaceuticals Factory
o Europharm Laboratoires
o Macfarlan Smith
· Codeine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Codeine Market, By Country
o U.S. Codeine Market
o Canada Codeine Market
o Mexico Codeine Market
o Europe
§ Europe Codeine Market, By Country
o Germany Codeine Market
o UK Codeine Market
o France Codeine Market
o Russia Codeine Market
o Italy Codeine Market
o Rest of Europe Codeine Market
o Asia-Pacific
§ Asia-Pacific Codeine Market, By Country
o China Codeine Market
o Japan Codeine Market
o South Korea Codeine Market
o India Codeine Market
o Southeast Asia Codeine Market
o Rest of Asia-Pacific Codeine Market
o South America
§ South America Codeine Market
o Brazil Codeine Market
o Argentina Codeine Market
o Columbia Codeine Market
o Rest of South America Codeine Market
o Middle East and Africa
§ Middle East and Africa Codeine Market
o Saudi Arabia Codeine Market
o UAE Codeine Market
o Egypt Codeine Market
o Nigeria Codeine Market
o South Africa Codeine Market
o Rest of MEA Codeine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Codeine Market, By Type
5.1. Introduction
5.2. Global Codeine Revenue and Market Share by Type (2017-2027)
5.2.1. Global Codeine Revenue and Revenue Share by Type (2017-2027)
5.3. Codeine Tablet
5.3.1. Global Codeine Tablet Revenue and Growth Rate (2017-2027)
5.4. Codeine Capsules
5.4.1. Global Codeine Capsules Revenue and Growth Rate (2017-2027)
5.5. Codeine Injection
5.5.1. Global Codeine Injection Revenue and Growth Rate (2017-2027)
5.6. Codeine Syrups
5.6.1. Global Codeine Syrups Revenue and Growth Rate (2017-2027)
6. Codeine Market, By Application
6.1. Introduction
6.2. Global Codeine Revenue and Market Share by Application (2017-2027)
6.2.1. Global Codeine Revenue and Revenue Share by Application (2017-2027)
6.3. Relieve Cough
6.3.1. Global Relieve Cough Revenue and Growth Rate (2017-2027)
6.4. Anesthesia and Sedation
6.4.1. Global Anesthesia and Sedation Revenue and Growth Rate (2017-2027)
6.5. Treat Mild to Moderate Pain
6.5.1. Global Treat Mild to Moderate Pain Revenue and Growth Rate (2017-2027)
7. Codeine Market, By Region
7.1. Introduction
7.2. Global Codeine Revenue and Market Share by Regions
7.2.1. Global Codeine Revenue by Regions (2017-2027)
7.3. North America Codeine by Countries
7.3.1. North America Codeine Revenue and Growth Rate (2017-2027)
7.3.2. North America Codeine Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Codeine by Countries
7.4.1. Europe Codeine Revenue and Growth Rate (2017-2027)
7.4.2. Europe Codeine Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Codeine by Countries
7.5.1. Asia-Pacific Codeine Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Codeine Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Codeine by Countries
7.6.1. South America Codeine Revenue and Growth Rate (2017-2027)
7.6.2. South America Codeine Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Codeine by Countries
7.7.1. Middle East and Africa Codeine Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Codeine Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Noramco
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Aesica
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Tasmanian Alkaloids
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Northeast pharmaceutical Group
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Luxembourg Medicine
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Qinghai Pharmaceutical Factory
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Marching Pharmaceutical
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Bright Future Pharmaceuticals Factory
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Europharm Laboratoires
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Macfarlan Smith
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Codeine Market Forecast (2017-2027)
9.1. Global Codeine Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Codeine Market Forecast by Regions (2017-2027)
9.2.1. North America Codeine Market Forecast (2017-2027)
9.2.1.1. United States Codeine Market Forecast (2017-2027)
9.2.1.2. Canada Codeine Market Forecast (2017-2027)
9.2.1.3. Mexico Codeine Market Forecast (2017-2027)
9.2.2. Europe Codeine Market Forecast (2017-2027)
9.2.2.1. Germany Codeine Market Forecast (2017-2027)
9.2.2.2. France Codeine Market Forecast (2017-2027)
9.2.2.3. UK Codeine Market Forecast (2017-2027)
9.2.2.4. Russia Codeine Market Forecast (2017-2027)
9.2.2.5. Italy Codeine Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Codeine Market Forecast (2017-2027)
9.2.3. Asia-Pacific Codeine Market Forecast (2017-2027)
9.2.3.1. China Codeine Market Forecast (2017-2027)
9.2.3.2. Japan Codeine Market Forecast (2017-2027)
9.2.3.3. Korea Codeine Market Forecast (2017-2027)
9.2.3.4. India Codeine Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Codeine Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Codeine Market Forecast (2017-2027)
9.2.4. South America Codeine Market Forecast (2017-2027)
9.2.4.1. Brazil Codeine Market Forecast (2017-2027)
9.2.4.2. Argentina Codeine Market Forecast (2017-2027)
9.2.4.3. Columbia Codeine Market Forecast (2017-2027)
9.2.4.4. Rest of South America Codeine Market Forecast (2017-2027)
9.2.5. Middle East and Africa Codeine Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Codeine Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Codeine Market Forecast (2017-2027)
9.2.5.3. Egypt Codeine Market Forecast (2017-2027)
9.2.5.4. Nigeria Codeine Market Forecast (2017-2027)
9.2.5.5. South Africa Codeine Market Forecast (2017-2027)
9.2.5.6. Turkey Codeine Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Codeine Market Forecast (2017-2027)
9.3. Codeine Market Forecast by Type (2017-2027)
9.3.1. Codeine Forecast by Type (2017-2027)
9.3.2. Codeine Market Share Forecast by Type (2017-2027)
9.4. Codeine Market Forecast by Application (2017-2027)
9.4.1. Codeine Forecast by Application (2017-2027)
9.4.2. Codeine Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Codeine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Codeine Revenue and Revenue Share by Type (2017-2018)
Figure Global Codeine Tablet Revenue and Growth Rate (2017-2018)
Figure Global Codeine Capsules Revenue and Growth Rate (2017-2018)
Figure Global Codeine Injection Revenue and Growth Rate (2017-2018)
Figure Global Codeine Syrups Revenue and Growth Rate (2017-2018)
Table Global Codeine Revenue and Revenue Share by Application (2017-2018)
Figure Global Relieve Cough Revenue and Growth Rate (2017-2018)
Figure Global Anesthesia and Sedation Revenue and Growth Rate (2017-2018)
Figure Global Treat Mild to Moderate Pain Revenue and Growth Rate (2017-2018)
Table Global Codeine Revenue by Regions (2017-2018)
Figure North America Codeine Growth Rate (2017-2018)
Figure North America Codeine Revenue and Growth Rate (2017-2018)
Figure North America Codeine by Countries (2017-2018)
Figure North America Codeine Revenue (Million USD) by Countries (2017-2018)
Figure United States Codeine Growth Rate (2017-2018)
Figure United States Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Codeine Growth Rate (2017-2018)
Figure Canada Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Codeine Growth Rate (2017-2018)
Figure Mexico Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Codeine Growth Rate (2017-2018)
Figure Europe Codeine Revenue and Growth Rate (2017-2018)
Figure Europe Codeine by Countries (2017-2018)
Figure Europe Codeine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Codeine Growth Rate (2017-2018)
Figure Germany Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Codeine Growth Rate (2017-2018)
Figure France Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Codeine Growth Rate (2017-2018)
Figure UK Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Codeine Growth Rate (2017-2018)
Figure Russia Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Codeine Growth Rate (2017-2018)
Figure Italy Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Codeine Growth Rate (2017-2018)
Figure Rest of Europe Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Codeine Growth Rate (2017-2018)
Figure Asia-Pacific Codeine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Codeine by Countries (2017-2018)
Figure Asia-Pacific Codeine Revenue (Million USD) by Countries (2017-2018)
Figure China Codeine Growth Rate (2017-2018)
Figure China Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Codeine Growth Rate (2017-2018)
Figure Japan Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Codeine Growth Rate (2017-2018)
Figure Korea Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Codeine Growth Rate (2017-2018)
Figure India Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Codeine Growth Rate (2017-2018)
Figure Southeast Asia Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Codeine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Codeine Growth Rate (2017-2018)
Figure South America Codeine Revenue and Growth Rate (2017-2018)
Figure South America Codeine by Countries (2017-2018)
Figure South America Codeine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Codeine Growth Rate (2017-2018)
Figure Brazil Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Codeine Growth Rate (2017-2018)
Figure Argentina Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Codeine Growth Rate (2017-2018)
Figure Columbia Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Codeine Growth Rate (2017-2018)
Figure Rest of South America Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Codeine Growth Rate (2017-2018)
Figure Middle East and Africa Codeine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Codeine by Countries (2017-2018)
Figure Middle East and Africa Codeine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Codeine Growth Rate (2017-2018)
Figure Saudi Arabia Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Codeine Growth Rate (2017-2018)
Figure United Arab Emirates Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Codeine Growth Rate (2017-2018)
Figure Egypt Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Codeine Growth Rate (2017-2018)
Figure Nigeria Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Codeine Growth Rate (2017-2018)
Figure South Africa Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Codeine Growth Rate (2017-2018)
Figure Turkey Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Codeine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Codeine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Noramco Codeine Financial Overview
Table Aesica Codeine Financial Overview
Table Tasmanian Alkaloids Codeine Financial Overview
Table Northeast pharmaceutical Group Codeine Financial Overview
Table Luxembourg Medicine Codeine Financial Overview
Table Qinghai Pharmaceutical Factory Codeine Financial Overview
Table Marching Pharmaceutical Codeine Financial Overview
Table Bright Future Pharmaceuticals Factory Codeine Financial Overview
Table Europharm Laboratoires Codeine Financial Overview
Table Macfarlan Smith Codeine Financial Overview
Figure Global Codeine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Codeine Market Forecast by Regions (2018-2025)
Figure North America Codeine Market Forecast (2018-2025)
Figure United States Codeine Market Forecast (2018-2025)
Figure Canada Codeine Market Forecast (2018-2025)
Figure Mexico Codeine Market Forecast (2018-2025)
Figure Europe Codeine Market Forecast (2018-2025)
Figure Germany Codeine Market Forecast (2018-2025)
Figure France Codeine Market Forecast (2018-2025)
Figure UK Codeine Market Forecast (2018-2025)
Figure Russia Codeine Market Forecast (2018-2025)
Figure Italy Codeine Market Forecast (2018-2025)
Figure Rest of Europe Codeine Market Forecast (2018-2025)
Figure Asia-Pacific Codeine Market Forecast (2018-2025)
Figure China Codeine Market Forecast (2018-2025)
Figure Japan Codeine Market Forecast (2018-2025)
Figure Korea Codeine Market Forecast (2018-2025)
Figure India Codeine Market Forecast (2018-2025)
Figure Southeast Asia Codeine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Codeine Market Forecast (2018-2025)
Figure South America Codeine Market Forecast (2018-2025)
Figure Brazil Codeine Market Forecast (2018-2025)
Figure Argentina Codeine Market Forecast (2018-2025)
Figure Columbia Codeine Market Forecast (2018-2025)
Figure Rest of South America Codeine Market Forecast (2018-2025)
Figure Middle East and Africa Codeine Market Forecast (2018-2025)
Figure Saudi Arabia Codeine Market Forecast (2018-2025)
Figure United Arab Emirates Codeine Market Forecast (2018-2025)
Figure Egypt Codeine Market Forecast (2018-2025)
Figure Nigeria Codeine Market Forecast (2018-2025)
Figure South Africa Codeine Market Forecast (2018-2025)
Figure Turkey Codeine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Codeine Market Forecast (2018-2025)
Figure Global Codeine Forecast by Type (2018-2025)
Figure Global Codeine Market Share Forecast by Type (2018-2025)
Figure Global Codeine Forecast by Type (2018-2025)
Figure Global Codeine Forecast by Application (2018-2025)
Figure Global Codeine Market Share Forecast by Application (2018-2025)
Figure Global Codeine Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|